| Tinto, Halidou |
| Active, not recruiting | 4 | 800 | RoW | Sulfadoxine pyrimethamine, SP, Amodiaquine, AQ | Malaria Consortium | Malaria | 10/22 | 12/23 | | |
SMC-RST, NCT04816461: Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates |
|
|
| Not yet recruiting | 4 | 789 | RoW | Amodiaquine Sulfadoxine-Pyrimethamin administration, Dihydroartemisinin-Piperaquine, Standard HRP2-RDT, Highly sensitive RDT | Institut de Recherche en Sciences de la Sante, Burkina Faso | Malaria | 06/23 | 06/23 | | |
| Recruiting | 3 | 16200 | RoW | R21Matrix M | London School of Hygiene and Tropical Medicine, National Malaria Control Programme, The Gambia | Malaria | 12/24 | 12/25 | | |
CALINA, NCT04300309: Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria |
|
|
| Terminated | 2/3 | 28 | RoW | artemether:lumefantrine (2.5 mg:30 mg) | Novartis Pharmaceuticals, European and Developing Countries Clinical Trials Partnership (EDCTP), Medicines for Malaria Venture (MMV), Switzerland, Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso, Institut de Recherche en sciences de la Santé - Unité de Recherche Clinique de Nanoro (IRSS-URCN), Burkina Faso | Plasmodium Falciparum Malaria | 07/23 | 05/24 | | |
NCT04081051: Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention |
|
|
| Completed | N/A | 17294 | RoW | diagnostic algorithm+Point of care rapid diagnostic tests+ Behavior change ( assessed together as a single package of interventions) | Foundation for Innovative New Diagnostics, Switzerland, University of Oxford, Indian Council of Medical Research, WHO, Special Programme for Research and Training in Tropical Diseases (TDR) | Acute Febrile Illness | 09/22 | 09/22 | | |
| Tougri, Gauthier M |
| Active, not recruiting | 4 | 800 | RoW | Sulfadoxine pyrimethamine, SP, Amodiaquine, AQ | Malaria Consortium | Malaria | 10/22 | 12/23 | | |
SMC-RST, NCT04816461: Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates |
|
|
| Not yet recruiting | 4 | 789 | RoW | Amodiaquine Sulfadoxine-Pyrimethamin administration, Dihydroartemisinin-Piperaquine, Standard HRP2-RDT, Highly sensitive RDT | Institut de Recherche en Sciences de la Sante, Burkina Faso | Malaria | 06/23 | 06/23 | | |
